Company to view next
Generic selectors
Exact matches only
Search in title
Search in content

Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma, ocular surface, and retinal diseases in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma. The company is also developing AR-15512 to treat signs and symptoms of dry eye; and AR-1105, AR-13503 SR, and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM. Aerie Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Durham, North Carolina.

Sector:

Healthcare

Industry:

Drug Manufacturers—Specialty & Generic

Employees:

365

Address:

Aerie Pharmaceuticals, Inc. 4301 Emperor Boulevard Suite 400 Durham NC 27703 United States

Website:

Home

Phone:

919-237-5300

Leave a comment

Your email address will not be published. Required fields are marked *